DUBLIN – (COMMERCIAL THREAD)–The “Hyperglycemia – Global Review of Clinical Trials, S1, 2021” clinical trials have been added to ResearchAndMarkets.com offer.

This report presents key data from clinical trials on hyperglycemia. The report includes an overview of the numbers of trials and their average number of registrations in major countries conducted around the world.

The report offers disease clinical trial coverage by region, country (G7 and E7), phase, trial status, endpoint status, and sponsor type. The report also provides important drugs for ongoing trials (based on number of ongoing trials). Clinical trial reports are generated using the publisher’s proprietary database: Pharma: clinical trials database.

Clinical trials are gathered from more than 80 clinical trial registers, conferences, journals, news, etc. different around the world. The clinical trials database is updated periodically by dynamic process.

The report improves decision-making abilities and helps create effective counter-strategies to gain competitive advantage.

Scope

  • Report Provides Overview of Global Clinical Trials Landscape

  • Report provides high level clinical trial data by region, country (G7 & E7), trial status, trial phase, sponsor type and endpoint status

  • The report reviews the main companies involved and identifies all trials (trial title, phase and status) related to the company

  • The report provides all unfinished trials (completed, suspended and withdrawn) with the reason for the failure

  • The report presents enrollment trends over the past five years

  • The report provides the latest news from the past three months

Reasons to buy

  • Help formulate key business investment strategies

  • Helps identify important locations for conducting clinical trials, saving time and money

  • Provides high-level analysis of the global clinical trials market which helps in identifying major business opportunities

  • Supports understanding of trial count and enrollment trends by country in the global therapeutics market

  • Helps interpret clinical trial success rates by providing a comparative scenario of completed and unfinished (completed, suspended or withdrawn) trials

  • Facilitates the evaluation of clinical trials of the indication at global, regional and national levels

Main topics covered:

  • Orientation report

  • Coverage of clinical trial reports

  • Clinical trials by region

  • Clinical trials and average enrollment by country

  • Clinical Trials from G7 Countries: Proportion of Hyperglycemia to Metabolic Disorders Clinical Trials

  • Clinical trials by phase in G7 countries

  • Clinical trials in G7 countries by trial status

  • Clinical trials by country E7: Proportion of hyperglycemia in relation to metabolic disorders Clinical trials

  • Clinical trials by phase in E7 countries

  • Clinical trials in E7 countries by trial status

  • Clinical trials by phase

  • Ongoing trials by phase

  • Clinical trials by trial status

  • Clinical trials by endpoint status

  • Subjects recruited over a period of time

  • Clinical trials by type of sponsor

  • Leading Sponsors

  • Main companies participating in clinical trials for the treatment of hyperglycemia

  • Important drugs

  • Snapshots of clinical trial profiles

  • appendix

Companies mentioned

  • Sanofi

  • Novo Holdings AS

  • Eli Lilly et Cie

  • Merck & Co Inc

  • AstraZeneca Plc

  • Novartis AG

  • Bristol-Myers Squibb Co

  • Medtronic Plc

  • Advance Pharmaceutical Co Ltd

  • Boston Therapeutics Inc

For more information on this clinical trials report, visit https://www.researchandmarkets.com/r/y7b21g



Source link

Leave a Reply

Your email address will not be published.